FW: lyme treatment

[Guest guest]

lyme treatment

Samento (Cat's Claw) is Producing Good Outcomes for Those with Lyme Disease

by Patti Kantor

A pilot study was recently conducted with 28 patients suffering from advanced

chronic Lyme disease. All the patients tested positive for the disease using the

Western Blot blood test for Borrelia Burgdorferi, the bacteria that causes Lyme

disease - which can also cause, mimic, or be a contributing factor to more than

300 other conditions.

UNRESPONSIVE TO ANTIBIOTICS

A control group was treated with conventional antibiotic treatment. At the end

of the study all the patients in this group continued to test positive for

Borrelia. None of the patients experienced an improvement in their clinical

condition and, in fact, some got worse.

SAMENTO GROUP IMPROVED

An experimental group was treated with Samento, also known as TOA-Free Cat's

Claw. At the end of the study, 85% of the patients in this group tested negative

for Borrelia, and all the patients experienced a dramatic improvement in their

clinical condition. A full report of the study, showing positive results of

reducing the infection also related to over 300 other conditions besides Lyme

disease, is to be available soon.

POAS PREFERRED OVER TOAS

Samento is a rare chemotype of a medicinal plant commonly known as TOA-Free

Cat's Claw. Its botanical name is Uncaria tomentosa. Unlike traditional Cat's

Claw products, it does not contain chemical antagonists called tetracyclic

oxindole alkaloids (TOAs).

TOAs act upon the central nervous system greatly inhibiting the positive effect

of the pentacyclic oxindole alkaloids (POAs), which primarily affect the immune

cells responsible for non-specific and cellular immunity, and demonstrate

powerful immune system modulating properties. TOAs can cause a 30% reduction in

immune system modulating properties that POAs provide. Samento contains a

standardized amount of POAs.

HOW BORRELIA EXISTS

The latest research on Borrelia burgdorferi (Bb) shows that it exists in at

least three different forms: the spirochete, the spheroplast (also known as

L-form), and the cyst form. During the course of infection, Bb can shift among

these three forms, converting from the spirochete form to the others when

presented with an unfavorable environment (antibiotics, changes in pH of body

fluids in chronic inflammation, etc.). It then reverts back to the spirochete

form to grow and reproduce upon being released from naturally aging and dying

infected cells. It is during the growth period after reconversion to the

spirochete form, as well as in adult spirochete form, that Bb is most vulnerable

and susceptible to antibiotics and natural elimination by the body's immune

system.

The severity of Lyme disease is directly related to the spirochete load: low

load results in mild or even asymptomatic infections. With increased spirochete

load from subsequent repeated infections and/or reactivated dormant infections,

the severity of the disease increases. Higher loads also impair key cells of the

immune system and modify the immune response, thus making the immune system

unable to fight the pathogen. The negative effects on the immune system increase

the longer the spirochetes are present.

To fight Lyme disease, it is necessary to not only restore the immune system to

normal functioning, but to boost it. Even a normal functioning immune system is

unable to attack and eliminate Bb in all its forms.

HOW SAMENTO WORKS

The results of research on Samento demonstrate its powerful immune system

modulating and stimulating properties, along with its pronounced

anti-inflammatory, antioxidant, and anti-infectious effects. The diverse

spectrum of the biological activities of Samento is due to its biologically

active compounds. The POAs contained in this chemotype are generally accepted as

the principal immunomodulating and immunostimulating agents.

POAs are actively involved in the repairing of immunity damaged by Borrelia and

other co-infections, assisting in restoring the immune system, enhancing its

ability to eliminate the pathogens by natural way.

In addition, this chemotype contains quinovic acid glycosides - compounds with

strong natural antibiotic properties (the latest generations of conventional

synthetic antibiotics named Quinolones are based on quinovic acid glycosides),

which further enhance the medicinal effect of Samento in fighting the infection.

Taking into account the lifetime of intracellular forms, it can be assumed that

continuous use of Samento for eight to 12 months would kill and eliminate

Borrelia, as well as any other infections, restoring the person's health.

http://herbalremedies.com/westnile.html half way down

[Guest guest]

In a message dated 10/21/2003 1:46:04 PM Eastern Standard Time,

tymetoplay2001@... writes:

> Samento is great but it was one part of a treatment plan used in the

> study.

>

>

THAT IS EXACTLY WHAT I SAY!!!!

You cannot just do the Samento..... you have to have an individual protocol

for each person!!

That is why I talk to each person individually.

sue massie, CNHP

732 933-4011

[Guest guest]

--

FYI, in the study... many other herbal formulas were also used,

individually picked as well as LBG treatments, massage, prayer or

positive thinking and Jin Shin type treatments, detox baths....

Samento is great but it was one part of a treatment plan used in the

study.

Byron

- In , " Marie " <AtTheLake@s...> wrote:

>

> lyme treatment

>

>

> Samento (Cat's Claw) is Producing Good Outcomes for Those with

Lyme Disease

> by Patti Kantor

>

> A pilot study was recently conducted with 28 patients suffering

from advanced chronic Lyme disease. All the patients tested positive

for the disease using the Western Blot blood test for Borrelia

Burgdorferi, the bacteria that causes Lyme disease - which can also

cause, mimic, or be a contributing factor to more than 300 other

conditions.

>

> UNRESPONSIVE TO ANTIBIOTICS

>

> A control group was treated with conventional antibiotic

treatment. At the end of the study all the patients in this group

continued to test positive for Borrelia. None of the patients

experienced an improvement in their clinical condition and, in fact,

some got worse.

>

> SAMENTO GROUP IMPROVED

>

> An experimental group was treated with Samento, also known as TOA-

Free Cat's Claw. At the end of the study, 85% of the patients in

this group tested negative for Borrelia, and all the patients

experienced a dramatic improvement in their clinical condition. A

full report of the study, showing positive results of reducing the

infection also related to over 300 other conditions besides Lyme

disease, is to be available soon.

>

> POAS PREFERRED OVER TOAS

>

> Samento is a rare chemotype of a medicinal plant commonly known as

TOA-Free Cat's Claw. Its botanical name is Uncaria tomentosa. Unlike

traditional Cat's Claw products, it does not contain chemical

antagonists called tetracyclic oxindole alkaloids (TOAs).

>

> TOAs act upon the central nervous system greatly inhibiting the

positive effect of the pentacyclic oxindole alkaloids (POAs), which

primarily affect the immune cells responsible for non-specific and

cellular immunity, and demonstrate powerful immune system modulating

properties. TOAs can cause a 30% reduction in immune system

modulating properties that POAs provide. Samento contains a

standardized amount of POAs.

>

> HOW BORRELIA EXISTS

>

> The latest research on Borrelia burgdorferi (Bb) shows that it

exists in at least three different forms: the spirochete, the

spheroplast (also known as L-form), and the cyst form. During the

course of infection, Bb can shift among these three forms,

converting from the spirochete form to the others when presented

with an unfavorable environment (antibiotics, changes in pH of body

fluids in chronic inflammation, etc.). It then reverts back to the

spirochete form to grow and reproduce upon being released from

naturally aging and dying infected cells. It is during the growth

period after reconversion to the spirochete form, as well as in

adult spirochete form, that Bb is most vulnerable and susceptible to

antibiotics and natural elimination by the body's immune system.

>

> The severity of Lyme disease is directly related to the spirochete

load: low load results in mild or even asymptomatic infections. With

increased spirochete load from subsequent repeated infections and/or

reactivated dormant infections, the severity of the disease

increases. Higher loads also impair key cells of the immune system

and modify the immune response, thus making the immune system unable

to fight the pathogen. The negative effects on the immune system

increase the longer the spirochetes are present.

>

> To fight Lyme disease, it is necessary to not only restore the

immune system to normal functioning, but to boost it. Even a normal

functioning immune system is unable to attack and eliminate Bb in

all its forms.

>

> HOW SAMENTO WORKS

>

> The results of research on Samento demonstrate its powerful immune

system modulating and stimulating properties, along with its

pronounced anti-inflammatory, antioxidant, and anti-infectious

effects. The diverse spectrum of the biological activities of

Samento is due to its biologically active compounds. The POAs

contained in this chemotype are generally accepted as the principal

immunomodulating and immunostimulating agents.

>

> POAs are actively involved in the repairing of immunity damaged by

Borrelia and other co-infections, assisting in restoring the immune

system, enhancing its ability to eliminate the pathogens by natural

way.

>

> In addition, this chemotype contains quinovic acid glycosides -

compounds with strong natural antibiotic properties (the latest

generations of conventional synthetic antibiotics named Quinolones

are based on quinovic acid glycosides), which further enhance the

medicinal effect of Samento in fighting the infection.

>

> Taking into account the lifetime of intracellular forms, it can be

assumed that continuous use of Samento for eight to 12 months would

kill and eliminate Borrelia, as well as any other infections,

restoring the person's health.

>

> http://herbalremedies.com/westnile.html half way down

>

>

>

>

>

>

[Guest guest]

lyme treatment

Dr. Atkinson-Barr CPhys PhD (Calabasas, CA) and Dr. Vernon

Padgett MD (Calabasas, CA) together with Dr. Horowitz MD (Hyde

Park, NY) are pleased to announce the discovery of a new treatment for

Lyme Disease using the antimicrobial metronidazole (Flagyl).

Metronidazole was introduced 40 years ago for the treatment of

trichomonas vaginalis and has previously been used for gingivitis,

giardia and anaerobic bacterial infections. Though metronidazole is less

widely used than it once was it is routinely available on prescription.

Lyme disease, named for the town of Lyme, Connecticut, is caused by the

spirochetal bacterium Borrelia burgdorferi and is normally contracted

from the bite of an infected deer tick Untreated or inadequately treated

Lyme disease progresses to a severely debilitating condition called

chronic or late-stage Lyme disease in which the spirochete affects the

brain, organs and joints of the patient resulting in almost complete

disability. Neurological effects include loss of cognitive function,

slurred speech, violent rages and memory loss.

Normal antibiotics, whether administered orally or by the intravenous

route, have been only partially successful in treating late-stage Lyme

disease leading some physicians to conclude that late-stage symptoms may

persist even after the infection had been cured.

Using metronidazole the authors have successfully treated late-stage

Lyme patients where conventional therapies have not been beneficial. In

particular severe neurological symptoms were eliminated leading to the

conclusion that Lyme symptoms are a consequence of an ongoing infection

and usual therapies are inadequate to treat the disease.

The authors have submitted a report of their discovery to the

prestigious New England Journal of Medicine for publication. Following

the initial work Dr. Horowitz confirmed the results in over 100 of his

most severely affected patients and will report those results at the

Lyme Federation Conference in New York, April 9-10th.

Lyme disease affects as many as 300,000 persons throughout the United

States and cases have been reported in all of the states with the

exception of Alaska and Hawaii. Lyme disease was recently confirmed to

be carried by ticks in Southern California. The current cost of

treatment and disability is estimated to be many billions of dollars and

areas with a high incidence of the disease, particularly Pennsylvania,

Rhode Island, Connecticut and New York, suffer from impacts on tourism

and real estate values.

Metronidazole is a simple and inexpensive treatment, costing $10 per

month, using tablets taken by mouth. The required duration of the

treatment is currently a matter of investigation though it is known that

improvement in patients continues even after 4 months of metronidazole

therapy. It is anticipated that metronidazole will be useful in the

early stages of Lyme disease and possibly as a topical cream for the

prevention of Lyme disease immediately following a tick bite.

Borrelia burgdorferi is one of a family of slow growing, spiral shaped

bacteria which have been implicated in several difficult diseases. If

metronidazole can be shown to be effective therapy against other similar

bacteria it may open new approaches to the treatment of other conditions

where there is evidence of a spirochetal cause including multiple

sclerosis and Alzheimer’s disease.

The authors believe that this is one of the first medical discoveries to

be made through the use of the Internet. Internet communication with

patients on the newsgroup sci.med.diseases.lyme allowed anecdotal

reports to be collected and Lyme patients to report their experiences.

One characteristic of Lyme treatment is that patient’s condition

initially deteriorates as the bacterium is killed. Using this

information Lyme patients were canvassed for any adverse reactions they

had experienced when taking metronidazole for unrelated conditions.